Budesonide Inhalation Formulation B (200 µg)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Budesonide Inhalation Formulation B (200 µg), covering 2015-11-02 to 2015-11-02. Get the full timeline:
Most recent: Clinical Trial Update: Bioequivalence Study of Two Inhalation Formulations Containing Budesonide 200 µg [Phase 1]